Abivax (ABVX) Assets (2021 - 2026)

Abivax (ABVX) posted quarterly Assets of $640.6 million for Q1 2026, up 264.78% year-over-year from $175.6 million in Q1 2025, and down 5.83% quarter-over-quarter from $680.2 million in Q4 2025.

Abivax (ABVX) Assets (2021 - 2026) Analysis & Trends

Abivax's Assets history runs 6 years deep, the most recent figure standing at $640.6 million for Q1 2026.

  • In Q1 2026, Assets rose 264.78% year-over-year to $640.6 million; the TTM figure through Mar 2026 stood at $640.6 million (up 264.78% YoY), while the FY2025 annual figure was $680.2 million, up 210.2% from the prior year.
  • Assets for Q1 2026 stood at $640.6 million, down from $680.2 million in the prior quarter.
  • The five-year high for Assets was $762.3 million in Q3 2025, with the low at $77.1 million in Q4 2022.
  • The 5-year median for Assets is $306.4 million (2024), against an average of $372.1 million.
  • The sharpest annual moves came in 2023 and 2025: Assets jumped 356.58% in 2023, then slumped 55.8% in 2025.
  • Abivax's Assets stood at $77.1 million in 2022, then surged by 356.58% to $351.9 million in 2023, then plunged by 37.69% to $219.3 million in 2024, then surged by 210.2% to $680.2 million in 2025, then declined by 5.83% to $640.6 million in 2026.
  • Business Quant data shows ABVX's Assets at $640.6 million in Q1 2026, $680.2 million in Q4 2025, and $762.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 27.42 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 41.73 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 10.03 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 4.32 Bn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 9.18 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 15.59 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 19.82 Bn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 5.56 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 2.10 Bn
10 Abivax 9.39 Bn 9.39 Bn - 640.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 640.56 Mn
Dec 31, 2025 680.20 Mn
Sep 30, 2025 762.28 Mn
Jun 30, 2025 135.43 Mn
Mar 31, 2025 175.60 Mn
Dec 31, 2024 219.28 Mn
Jun 30, 2024 306.37 Mn
Dec 31, 2023 351.90 Mn
Dec 31, 2022 77.07 Mn
Dec 31, 2021 124.96 Mn